Showing results (111-120 of 188) with videos related to

Sort By:
Pageof 19
Scientific Reports|May 20, 2017
A Molecular Basis for Selective Antagonist Destabilization of Dopamine D<sub>3</sub> Receptor Quaternary OrganizationSara Marsango, Gianluigi Caltabiano, Mireia Jiménez-Rosés, et al.
Biological Psychiatry|August 25, 2007
CRF1 not glucocorticoid receptors mediate prepulse inhibition deficits in mice overexpressing CRFLucianne Groenink, Anneloes Dirks, P Monika Verdouw, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 16, 2015
Modulation by Trace Amine-Associated Receptor 1 of Experimental Parkinsonism, L-DOPA Responsivity, and Glutamatergic NeurotransmissionAlexandra Alvarsson, Xiaoqun Zhang, Tiberiu L Stan, et al.
The International Journal of Neuropsychopharmacology|October 16, 2010
The melatonergic agonist and clinically active antidepressant, agomelatine, is a neutral antagonist at 5-HT(2C) receptorsMark J Millan, Philippe Marin, Maud Kamal, et al.
The International Journal of Neuropsychopharmacology|April 23, 2015
Biomarkers for Psychiatry: The Journey from Fantasy to Fact, a Report of the 2013 CINP Think TankElizabeth Scarr, Mark J Millan, Sabine Bahn, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 3, 2008
Neurokinin1 antagonists potentiate antidepressant properties of serotonin reuptake inhibitors, yet blunt their anxiogenic actions: a neurochemical, electrophysiological, and behavioral characterizationAlain Gobert, Mauricette Brocco, Anne Dekeyne, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|March 8, 2002
Characterization of phospholipase C activity at h5-HT2C compared with h5-HT2B receptors: influence of novel ligands upon membrane-bound levels of [3H]phosphatidylinositolsDidier Cussac, Adrian Newman-Tancredi, Yann Quentric, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 22, 2002
Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. II. Agonist and antagonist properties at subtypes of dopamine D(2)-like receptor and alpha(1)/alpha(2)-adrenoceptorAdrian Newman-Tancredi, Didier Cussac, Valérie Audinot, et al.
Journal of Neurochemistry|December 8, 2011
Pre-synaptic dopamine D(3) receptor mediates cocaine-induced structural plasticity in mesencephalic dopaminergic neurons via ERK and Akt pathwaysGinetta Collo, Federica Bono, Laura Cavalleri, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 23, 2006
Antiparkinsonian effects of the novel D3/D2 dopamine receptor agonist, S32504, in MPTP-lesioned marmosets: Mediation by D2, not D3, dopamine receptorsMichael P Hill, Paula Ravenscroft, Steven G McGuire, et al.
Pageof 19